Fidelity Select Pharmaceuticals Portfolio (FPHAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
22.79
-0.18 (-0.78%)
May 9, 2025, 8:04 PM EDT
Fund Assets 1.16B
Expense Ratio 0.67%
Min. Investment $0.00
Turnover n/a
Dividend (ttm) 1.12
Dividend Yield 4.78%
Dividend Growth 1.46%
Payout Frequency Semi-Annual
Ex-Dividend Date Apr 11, 2025
Previous Close 22.97
YTD Return -9.42%
1-Year Return -16.72%
5-Year Return 35.99%
52-Week Low 22.01
52-Week High 31.58
Beta (5Y) 0.57
Holdings 60
Inception Date Jun 18, 2001

About FPHAX

The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. It invests in domestic and foreign issuers. The fund invests primarily in common stocks. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

Fund Family Fidelity
Category Health
Stock Exchange NASDAQ
Ticker Symbol FPHAX
Index S&P 500 TR

Performance

FPHAX had a total return of -16.72% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.90%.

Chart

Bar chart with 6 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from -16.715010877447426 to 7.896.
End of interactive chart.

Top 10 Holdings

76.87% of assets
Name Symbol Weight
Eli Lilly and Company LLY 24.89%
Novo Nordisk A/S NVO 12.25%
AstraZeneca PLC AZN 10.29%
GSK plc GSK 5.63%
Gilead Sciences, Inc. GILD 5.44%
Merck & Co., Inc. MRK 5.29%
UCB SA UCB 4.87%
Royalty Pharma plc RPRX 2.98%
Fidelity Cash Central Fund n/a 2.90%
Elanco Animal Health Incorporated ELAN 2.31%
View More Holdings

Dividend History

Ex-Dividend Amount Pay Date
Apr 11, 2025 $0.861 Apr 14, 2025
Dec 26, 2024 $0.254 Dec 27, 2024
Apr 12, 2024 $0.227 Apr 15, 2024
Dec 21, 2023 $0.872 Dec 22, 2023
Apr 14, 2023 $1.035 Apr 17, 2023
Dec 16, 2022 $0.925 Dec 19, 2022
Full Dividend History